Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 November 2006

Antibiotic resistance of pediatric isolates of Streptococcus pneumoniae in a Saudi Arabian hospital from 1999 to 2004

Jaffar A. Al-Tawfiq

Med Sci Monit 2006; 12(11): CR471-475 :: ID: 462702

Abstract

Background: This study describes the resistance pattern of Streptococcus pneumoniae isolates obtained from pediatric patients in a Saudi Arabian hospital.
Material/Methods: This is a retrospective analysis of the antibiotic resistance of S. pneumoniae isolates (n=141) obtained from children in a Saudi Arabian hospital 1999–2004. Clinical data and antibiotic sensitivity were retrieved from microbiology data and analyzed.
Results: Of the total isolates of S. pneumoniae, 57.6% were susceptible to penicillin, 28.8% intermediately susceptible, and 13.7% were resistant organisms. Over the study period, high-level penicillin resistance of S. pneumoniae was 0% in 1999, 23% in 2001, and 3.4% in 2004. Intermediate penicillin resistance was 21% in 1999, 41% in 2001, and 27.6% in 2004. The resistance rates to other antibiotics were as follows: erythromycin 33.4%, tetracycline 30%, trimethoprim sulfamethoxazole 40%, and clindamycin 21.6%. Children less than 2 years of age showed a higher rate of intermediately penicillin-susceptible isolates (41.9% versus 22.7%, P=0.0.02). They also had higher rates of resistance to tetracycline (42.4% versus 25%, P=0.03), trimethoprim-sulfamethoxazole (54% versus 33.8%, P=0.02), and clindamycin (33% versus 17%, P=0.04). All tested isolates were susceptibility to ceftriaxone and vancomycin.
Conclusions: The overall high-level penicillin resistance of S. pneumonaie from 1999–2004 was 13.7%. The percentage of intermediately penicillin-susceptible organisms was higher in the age group under 2 years of age (41.9%) than in patients 2 years of age or older (22.7%).

Keywords: Streptococcus pneumoniae - metabolism, Streptococcal Infections - drug therapy, Saudi Arabia, Pneumococcal Infections - drug therapy, Penicillins - pharmacology, Penicillin Resistance, Microbial Sensitivity Tests, Anti-Bacterial Agents - pharmacology, Drug Resistance, Microbial, Child, Preschool, Child, Adolescent

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

08 Feb 2024 : Clinical Research  

Serum Selenium Concentration as a Potential Diagnostic Marker for Early-Stage Colorectal Cancer: A Comparat...

Med Sci Monit In Press; DOI: 10.12659/MSM.942882  

09 Feb 2024 : Clinical Research  

Factors Influencing the Occurrence of Intraoperative Hypothermia in Patients Undergoing General Anesthesia ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943463  

13 Feb 2024 : Clinical Research  

A Retrospective Study to Compare the Glasgow Coma Score, Pediatric Trauma Score, and Injury Severity Score ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943501  

16 Feb 2024 : Clinical Research  

Etiology, Clinical Presentation, and Outcomes of Bacterial Meningitis in Adult Patients: A Retrospective St...

Med Sci Monit In Press; DOI: 10.12659/MSM.942904  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750